EIF5A2 and neoplasm: In addition, Twist siRNA (a critical regulator in EMT) and eIF5A2 plasmid/eIF5A2 siRNA were co-transfected into tumor cells followed by determination of cell viabilities in HCT116, HT29, LOV0 and SW480 cells.